Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
Journal of Thrombosis and Haemostasis2020Vol. 18(7), pp. 1752–1755
Citations Over TimeTop 10% of 2020 papers
Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, Livia A. Veress, Michael B. Yaffe, Hunter B. Moore, Christopher D. Barrett
Related Papers
- → Acute respiratory distress syndrome mimics: the role of lung biopsy(2016)43 cited
- → Molecular mechanism of sustained inflation in acute respiratory distress syndrome(2012)10 cited
- → An autopsy case of severe alkaline burn(2012)
- → New insights on relationship of acute respiratory distress syndrome and diffuse alveolar damage(2020)
- → Serum Surfactant Protein-D (SP-D) Level: Does it Correlates with Pulmonary Compliance and ARDS in Severe Cases of COVID-19?(2022)